abstract |
The present invention relates to a novel triagen compound, a method for producing the same, a pharmaceutical composition containing the compound, and a use of the compound for the treatment of human cancer disease. Compared with known triazene compounds, the novel triazene compounds differ in that their action is improved while reducing toxicity, i.e. fewer side effects. |